2020
DOI: 10.1007/s10103-020-03042-x
|View full text |Cite
|
Sign up to set email alerts
|

Photobiomodulation therapy for male infertility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 53 publications
0
8
0
2
Order By: Relevance
“…The presence of opsins in the spermatozoa, the modification of the mitochondrial activity, and activation of plasma membrane receptors from the transient receptor potential (TRP) family of proteins have been suggested as possible mechanisms of action of the illumination on the sperm functionality [21][22][23][24][25]. However, in this study, these reported changes in the sperm parameters had no effect on the subsequent reproductive outcomes, measured in terms of farrowing rate and litter size under commercial conditions.…”
Section: Discussionmentioning
confidence: 60%
“…The presence of opsins in the spermatozoa, the modification of the mitochondrial activity, and activation of plasma membrane receptors from the transient receptor potential (TRP) family of proteins have been suggested as possible mechanisms of action of the illumination on the sperm functionality [21][22][23][24][25]. However, in this study, these reported changes in the sperm parameters had no effect on the subsequent reproductive outcomes, measured in terms of farrowing rate and litter size under commercial conditions.…”
Section: Discussionmentioning
confidence: 60%
“…Considered to be the mainstream treatment method for the estrogen receptor-positive breast cancer treatment regimen, aromatase inhibitors have been continuously used under the title of first-, second-, and third-generation aromatase inhibitors as approved by the FDA. The third-generation inhibitors comprise of letrozole, anastrozole, and exemestanea, which are used in the standard treatment of postmenopausal breast cancer these days. , In many studies, their use has been reported in reproductive technology, endometriosis, gynecomastia, ovarian cancers, male infertility, and many others …”
Section: Introductionmentioning
confidence: 99%
“…The third-generation inhibitors comprise of letrozole, anastrozole, and exemestanea, which are used in the standard treatment of postmenopausal breast cancer these days. 6,7 In many studies, their use has been reported in reproductive technology, 8 endometriosis, 9 gynecomastia, 10 ovarian cancers, 11 male infertility, 12 and many others. 13 Although the treatment using both steroidal and nonsteroidal aromatase inhibitors as third-generation aromatase inhibitors has gained tremendous attention, a few major side effects such as arthralgia, myalgia, hot flashes, night sweats, loss of sex drive, and vaginal dryness were observed in case of their prolonged clinical usage.…”
Section: Introductionmentioning
confidence: 99%
“…Men infertility affects more than 12% of the whole population and it is considered a multifactorial phenomenon [ 3 , 4 ]. It is widely accepted that medical intervention, i.e., Assisted Reproductive Techniques (ART), could be employed to circumvent male factors to some extent [ 5 , 6 ] and this implies a proper male gamete selection. However, the routinary semen analysis does not investigate possible sperm nucleic acids alteration such as DNA fragmentation, damage or epigenetic modifications (i.e., DNA methylation) [ 7 ], which significantly modify the semen quality parameters as well as the fertilization and implantation rates [ 8 ].…”
Section: Introductionmentioning
confidence: 99%